A shift in the beta-blocker treatment paradigm has arrived with the changing myocardial infarction treatment landscape, said ...

In the ABYSS trial, researchers found that interrupting a beta-blocker in patients after a myocardial infarction resulted in ...

The benefits of complete revascularization over culprit-only coronary artery revascularization were confirmed in older patients with ST-segment elevation myocardial infarction (STEMI) and ...

Young patients with myocardial infarction (MI) and fewer traditional risk factors often have greater exposure to urban noise, ...

Percutaneous coronary intervention (PCI) has proven lifesaving: Morbidity and mortality outcomes are significantly improved ...

Long-term use of beta-blockers in patients with myocardial infarction and preserved heart function does not significantly ...

During a massive heart attack, a large portion of the heart doesn’t receive oxygen due to a blocked artery. Quick treatment ...

The cardiovascular safety of interrupting beta-blocker could not be shown in comparison to continuation in patients with a history of myocardial infarction (MI) and there was no benefit to the ...

(Editor's note: The NCDR-Action Registry will incorporate and replace the National Registry of Myocardial Infarction, which has collected data on more than 2.3 million acute MI patients and helped ...

In a large meta-analysis, complete revascularisation reduced cardiovascular events compared with culprit-only revascularisation in older patients with a myocardial infarction and multivessel disease ...

Background In acute heart failure (HF), reduced cardiac output, vasoconstriction and congestion may damage the intestinal ...

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...